A nanosecond laser based surgical treatment to prevent progression to vision loss in early Age-related macular degeneration (AMD)

我们的目标是进行一项新的纳米激光治疗黄斑变性（AMD）的试验，如果成功减缓AMD的进展，将导致我们社区视力丧失的急剧减少。AMD是澳大利亚50岁及以上人群不可逆视力丧失的主要原因。成功的结果将推迟视力丧失，使成千上万的澳大利亚人受益，并节省大量的医疗费用。

We aim to conduct a trial of a new nano-laser based treatment for Age-related Macular Degeneration (AMD) which, if successful in slowing progression of AMD, will lead to a dramatic reduction in vision loss in our community. AMD is the leading cause of irreversible vision loss in people 50 years and older in Australia. The successful outcome will postpone vision loss, benefiting many thousands of Australians, and result in substantial healthcare savings.